FDA Outlines When Digital Tools for Stress Management and Mindful Movement Qualify as Medical Devices

FDA Draft Guidance Clarifies When Digital Health Technologies for Stress and Physical Activity Qualify as Medical Devices

The FDA issued draft guidance on September 28, 2023 that spells out when apps, wearables and sensors used to monitor stress or track physical activity count as medical devices. The document separates general wellness tools from those intended to diagnose, treat or mitigate specific diseases. It supplies concrete examples and applies a risk-based framework drawn from earlier policies on software functions and low-risk devices.

What this means

The draft creates sharper boundaries for product makers. Apps focused on general stress relief or daily movement usually stay free of device rules. Products that claim to address clinical anxiety, aid cardiac recovery or manage named diseases cross into regulated territory. Over time this could shape which features reach consumers first and how companies label their offerings.

Key takeaways

• FDA draft guidance issued September 28, 2023, applies to digital health technologies for stress and physical activity and separates general wellness claims from medical ones. [1]
• General wellness products that promote physical activity or stress management without specific disease claims are not regulated as medical devices. [2]
• Technologies intended to measure or improve stress tied to a disease or condition may meet the statutory definition of a device and face oversight. [3]
• The agency applies a risk-based framework that favors the least burdensome regulatory path when review is needed. [1]
• Stakeholder comments on the draft will help refine the final policy for these tools. [1]

When tools cross into regulated territory

A stress-monitoring wearable qualifies as a regulated medical device when its marketing or labeling shows intent to diagnose, treat or mitigate a specific disease. Heart-rate-variability sensors sold to help manage diagnosed anxiety disorders illustrate this category. In contrast, the same sensor marketed for everyday relaxation tracking typically remains outside FDA device rules. [3]

Physical activity monitoring examples

Tools that encourage general fitness or physical activity without disease claims fall outside oversight. Simple step counters or apps that promote overall well-being fit this description. Devices promoted for post-stroke motor recovery or cardiac rehabilitation, however, can trigger regulation because they target named medical conditions. [1]

Connection to earlier policies

This draft builds directly on two prior FDA documents. One covers software functions and mobile medical applications. The other sets the 2019 general wellness policy for low-risk devices. The new text supplies concrete examples tied to stress and activity monitoring that earlier versions left less defined. [2]

Limitations

Guidance remains in draft form and is subject to revision after the public comment period. It does not address data privacy, cybersecurity standards, or requirements for clinical outcome validation in detail. Long-term real-world impact on device developers and health equity outcomes is not yet known. Sources focus on U.S. regulatory perspective with limited international harmonization details.

FAQ

Under what circumstances does a stress-monitoring wearable qualify as a regulated medical device?
It qualifies when intended to diagnose, treat or mitigate a specific disease or condition rather than support general wellness.

What examples does the FDA provide for physical activity technologies that fall outside FDA oversight?
Technologies that promote physical activity or mindful movement without claims about treating or preventing particular diseases stay unregulated.

How does this draft guidance align with or update prior policies on software as a medical device and general wellness products?
It adds specific examples for stress and activity tools while preserving the risk-based approach and wellness distinction laid out in earlier documents.

Last updated: August 24, 2026